Datiles M B, Magno B V, Freidlin V
National Eye Institute, National Institutes of Health, Bethesda, MD 20892-1860, USA.
Br J Ophthalmol. 1995 Jun;79(6):527-34. doi: 10.1136/bjo.79.6.527.
A study was conducted to determine the capability of the recently developed National Eye Institute (NEI) Scheimpflug cataract imaging system in detecting changes in the nuclear region of the lens over a 1 year period.
Twenty five eyes with pure nuclear cataracts with mean nuclear densities < or = 0.30 optical density units (ODU) as well as 30 normal control eyes were each examined at baseline and 12 months later. Computerised densitometry using the NEI Scheimpflug cataract imaging system was performed. Clinical grading of the lenses was also done using the Lens Opacities Classification System II (LOCS II). For densitometry, a change of plus or minus 0.023 ODU (the 99% range) in mean density in the nuclear area was considered a progression or regression at 1 year.
Using the Scheimpflug densitometry, 14 of the 25 cataractous eyes showed significant progression at 1 year. In the normal control group, only three of the 30 eyes showed significant progression. In contrast, using the LOCS II clinical grading, only two of the 25 cataractous eyes showed a one step increase, two of the 30 controls progressed at 1 year, and none regressed. There was no significant difference in visual acuity.
This study suggests the value of the NEI Scheimpflug cataract imaging system in detecting nuclear change within 1 year. However, clinically significant changes may require longer follow up periods. These data will be useful in planning future longitudinal studies of nuclear cataracts, such as for clinical trials of anticataract drugs.
开展一项研究以确定最近研发的美国国立眼科研究所(NEI)的Scheimpflug白内障成像系统在检测晶状体核区1年内变化的能力。
对25只平均核密度≤0.30光密度单位(ODU)的纯核性白内障眼以及30只正常对照眼在基线期和12个月后分别进行检查。使用NEI Scheimpflug白内障成像系统进行计算机化密度测定。还使用晶状体混浊分类系统II(LOCS II)对晶状体进行临床分级。对于密度测定,核区平均密度变化±0.023 ODU(99%范围)被视为1年时的进展或消退。
使用Scheimpflug密度测定法,25只白内障眼中有14只在1年时显示出显著进展。在正常对照组中,30只眼中只有3只显示出显著进展。相比之下,使用LOCS II临床分级时,25只白内障眼中只有2只显示有一步进展,30只对照眼中有2只在1年时进展,且无一只出现消退。视力无显著差异。
本研究提示NEI Scheimpflug白内障成像系统在检测1年内晶状体核变化方面的价值。然而,具有临床意义的变化可能需要更长的随访期。这些数据将有助于规划未来核性白内障的纵向研究,例如抗白内障药物的临床试验。